🔥 Top 5 — Most important news of the week

Bio-Tech Company Agenus aiming to raise $100 million using an STO



Agenus Inc. announced its Security Token Offering, launching the Biotech Electronic Security Token (BEST) in order to fund future drug development. The BEST token will be backed by AGEN2034, a immunology drug that renerated around $15 billion in revenue in 2018. Investors will have equity ownership and access to future sales of the drug, which is currently in pivotal preliminary tests.

-> source

2. Official Launch of STOCOOP — a cooperative organization for STOs



Initiated and established by The Cabin Capital and OpenFinance, STOCOOP understands itsself as an international cooperative organization for Security Token Offerings. Last week at the Seoul Blockchain Convergency Summit, the official lauch of STOCOOP was announced. We wrote a short article about the purpose of this new formed coalition and outlined its 10 founding members.

-> source

3. TokenSoft’s Beta — providing Custody Service for Security Tokens — goes LIVE



With the launch of „The Knox wallet“, TokenSoft Inc. is presenting the first cold-storage custody service that is designed specifically for Security Tokens. It is supporting ERC-20, ERC-1404, DS-20 (Securitize), ST-20 (Polymath) and Harbor’s R tokens as well as Bitcoin and Ether.

-> source



4. 75 million POLY locked up for 5 Years



Polymath, a platform helping companies to issue Security Tokens, is locking up 75 Million POLY (from a total of 1 billion that were created) in a smart contract until 01.01.2024. The purpose is to safe-keep them and prevent these tokens from being compromised in a hack. POLY tokens can be used within Polymath’s platform to create Security Tokens, register token symbols, and use audited smart contracts to raise funds in an automated fashion.

-> source



5. Symbiont closes $20M Series B funding round led by Nasdaq Ventures



Symbiont, a fintech company building blockchain applications for institutional players in the capital markets, received a $20m funding with participation from investors such as Nasdaq Ventures, Citi, Galaxy Digital, Raptor Group and others. In an interview with CoinDesk, CEO Mark Smith explained how his company can help to combine blockchain with traditional exchange technology.

He stated: „Symbiont will give Nasdaq the ability to originate a financial instrument and the smart contract to custody it on a blockchain, to allow trading to occur with their matching engine, to allow surveillance to occur across the network using Nasdaq technology and then to perform settlement on a blockchain” -> source